News | August 11, 2021
Cadila Healthcare net profit at Rs 587.2 cr in Q1FY22
The company has also applied to DCGI for Emergency Use Authorization (EUA) for ZyCoVD, the world's first Plasmid DNA Vaccine
The company has also applied to DCGI for Emergency Use Authorization (EUA) for ZyCoVD, the world's first Plasmid DNA Vaccine
Deal signed with AOP Orphan for US commercial rights
A veteran in cell therapy and oncology commercialisation
The drug is indicated for mild and transient episodes of heart block
Partnership enables broad reach of cfDNA methylation blood tests for early cancer detection
Takeda Will Focus its Efforts on Dengue, Zika and Pandemic vaccines
As per the agreement, Lonza will provide commercial-scale manufacture of monoclonal antibodies
Bayer Zydus Pharma will continue to operate in core therapies with new products in the pipeline
The company is exploring all legal options to challenge the award.
MEK inhibitor compound (LNP3794) developed as part of its oncology pipeline had previously shown pre-clinical activity as a single agent as well as in combination
Subscribe To Our Newsletter & Stay Updated
